Literature DB >> 2049366

Negative symptoms: psychopathological models.

J Ananth1, A Djenderdjian, P Shamasunder, J Costa, J Herrera, J Sramek.   

Abstract

The psychopathological manifestations of schizophrenia have been broadly divided into positive and negative symptom groups. Even though there is no definitive consensus, psychomotor agitation, motor excitement, hallucinations, delusions and thought disorder constitute positive and psychomotor retardation, amotivation, apathy and decreased emotional expression are grouped into negative symptoms. The negative symptoms have been reported to appear late in the course of the illness and resistant to treatment with neuroleptics. While these claims have not been substantiated, the current interest on negative symptoms is related to the fact that many nonfunctioning institutionalized as well as ambulatory schizophrenics manifest negative symptoms. As chronic psychiatric beds have become scarce, many patients with negative symptoms who were harbored in the chronic mental hospitals have been released to the community care and some of these patients live on the streets. Thus their visibility has challenged psychiatry to focus its efforts on the etiology and treatment of negative symptoms.

Entities:  

Mesh:

Year:  1991        PMID: 2049366      PMCID: PMC1188282     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  51 in total

1.  CHANGES IN SCHIZOPHRENIC PSYCHOPATHOLOGY AND WARD BEHAVIOUR AS A FUNCTION OF PHENOTHIAZINE TREATMENT.

Authors:  S C GOLDBERG; G L KLERMAN; J O COLE
Journal:  Br J Psychiatry       Date:  1965-02       Impact factor: 9.319

2.  Pneumoencephalographic studies in mental disease.

Authors:  J O HAUG
Journal:  Acta Psychiatr Scand Suppl       Date:  1962

3.  "Akinetic depression" in schizophrenia.

Authors:  T Van Putten; R P May
Journal:  Arch Gen Psychiatry       Date:  1978-09

4.  Computerised tomographic scan changes in manic-depressive illness.

Authors:  G D Pearlson; A E Veroff
Journal:  Lancet       Date:  1981-08-29       Impact factor: 79.321

5.  Normal ventricles in young schizophrenics.

Authors:  F Benes; P Sunderland; B D Jones; M LeMay; B M Cohen; J F Lipinski
Journal:  Br J Psychiatry       Date:  1982-07       Impact factor: 9.319

6.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

7.  Pneumo-encephalographic and computerized axial tomography scan changes in affective disorder.

Authors:  H M Standish-Barry; N Bouras; P K Bridges; J R Bartlett
Journal:  Br J Psychiatry       Date:  1982-12       Impact factor: 9.319

8.  A long-term follow-up study of schizophrenia: psychiatric course of illness and prognosis.

Authors:  G Huber; G Gross; R Schüttler
Journal:  Acta Psychiatr Scand       Date:  1975-07       Impact factor: 6.392

9.  Cognitive impairment associated with morphological brain abnormalities on computed tomography in chronic schizophrenic patients.

Authors:  E F Donnelly; D R Weinberger; I N Waldman; R J Wyatt
Journal:  J Nerv Ment Dis       Date:  1980-05       Impact factor: 2.254

10.  Neurological soft signs and psychopathology. I. Findings in schizophrenia.

Authors:  S M Cox; A M Ludwig
Journal:  J Nerv Ment Dis       Date:  1979-03       Impact factor: 2.254

View more
  2 in total

Review 1.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

2.  The effects of bupropion on negative symptoms in schizophrenia.

Authors:  Mojtaba Yassini; Neda Shariat; Mohammad Nadi; Fariba Amini; Mohammad Vafaee
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.